Global Genomics In Cancer Care Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Genomics In Cancer Care Market Overview

• 1.1 Product Overview and Scope of Genomics In Cancer Care
• 1.2 Classification of Genomics In Cancer Care by Type
  • 1.2.1 Global Genomics In Cancer Care Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Genomics In Cancer Care Revenue Market Share by Type in 2019
  • 1.2.3 Instruments
  • 1.2.4 Consumables
  • 1.2.5 Services
• 1.3 Global Genomics In Cancer Care Market by Application
  • 1.3.1 Overview: Global Genomics In Cancer Care Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Diagnostics
  • 1.3.3 Personalized Medicine
  • 1.3.4 Drug Discovery
  • 1.3.5 Development
  • 1.3.6 Research
• 1.4 Global Genomics In Cancer Care Market by Regions
  • 1.4.1 Global Genomics In Cancer Care Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Genomics In Cancer Care (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Genomics In Cancer Care Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Genomics In Cancer Care Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomics In Cancer Care Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Genomics In Cancer Care Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomics In Cancer Care Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Illumina
  • 2.1.1 Illumina Details
  • 2.1.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Illumina SWOT Analysis
  • 2.1.4 Illumina Product and Services
  • 2.1.5 Illumina Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Danaher
  • 2.2.1 Danaher Details
  • 2.2.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Danaher SWOT Analysis
  • 2.2.4 Danaher Product and Services
  • 2.2.5 Danaher Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Roche
  • 2.3.1 Roche Details
  • 2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Roche SWOT Analysis
  • 2.3.4 Roche Product and Services
  • 2.3.5 Roche Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Thermo Fisher scientific
  • 2.4.1 Thermo Fisher scientific Details
  • 2.4.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Thermo Fisher scientific SWOT Analysis
  • 2.4.4 Thermo Fisher scientific Product and Services
  • 2.4.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Bio-Rad
  • 2.5.1 Bio-Rad Details
  • 2.5.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Bio-Rad SWOT Analysis
  • 2.5.4 Bio-Rad Product and Services
  • 2.5.5 Bio-Rad Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Agilent
  • 2.6.1 Agilent Details
  • 2.6.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Agilent SWOT Analysis
  • 2.6.4 Agilent Product and Services
  • 2.6.5 Agilent Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Pacific Biosciences
  • 2.7.1 Pacific Biosciences Details
  • 2.7.2 Pacific Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Pacific Biosciences SWOT Analysis
  • 2.7.4 Pacific Biosciences Product and Services
  • 2.7.5 Pacific Biosciences Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Beckman Coulter
  • 2.8.1 Beckman Coulter Details
  • 2.8.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Beckman Coulter SWOT Analysis
  • 2.8.4 Beckman Coulter Product and Services
  • 2.8.5 Beckman Coulter Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Cancer Genetics
  • 2.9.1 Cancer Genetics Details
  • 2.9.2 Cancer Genetics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Cancer Genetics SWOT Analysis
  • 2.9.4 Cancer Genetics Product and Services
  • 2.9.5 Cancer Genetics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Sigma Aldrich
  • 2.10.1 Sigma Aldrich Details
  • 2.10.2 Sigma Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Sigma Aldrich SWOT Analysis
  • 2.10.4 Sigma Aldrich Product and Services
  • 2.10.5 Sigma Aldrich Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Qiagen
  • 2.11.1 Qiagen Details
  • 2.11.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Qiagen SWOT Analysis
  • 2.11.4 Qiagen Product and Services
  • 2.11.5 Qiagen Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Quest Diagnostics
  • 2.12.1 Quest Diagnostics Details
  • 2.12.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Quest Diagnostics SWOT Analysis
  • 2.12.4 Quest Diagnostics Product and Services
  • 2.12.5 Quest Diagnostics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 GE Healthcare
  • 2.13.1 GE Healthcare Details
  • 2.13.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 GE Healthcare SWOT Analysis
  • 2.13.4 GE Healthcare Product and Services
  • 2.13.5 GE Healthcare Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 PerkinElmer
  • 2.14.1 PerkinElmer Details
  • 2.14.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 PerkinElmer SWOT Analysis
  • 2.14.4 PerkinElmer Product and Services
  • 2.14.5 PerkinElmer Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Luminex
  • 2.15.1 Luminex Details
  • 2.15.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Luminex SWOT Analysis
  • 2.15.4 Luminex Product and Services
  • 2.15.5 Luminex Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.16 Thermo Fisher scientific
  • 2.16.1 Thermo Fisher scientific Details
  • 2.16.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.16.3 Thermo Fisher scientific SWOT Analysis
  • 2.16.4 Thermo Fisher scientific Product and Services
  • 2.16.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
• 2.17 Oxford Gene Technology
  • 2.17.1 Oxford Gene Technology Details
  • 2.17.2 Oxford Gene Technology Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.17.3 Oxford Gene Technology SWOT Analysis
  • 2.17.4 Oxford Gene Technology Product and Services
  • 2.17.5 Oxford Gene Technology Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Genomics In Cancer Care Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Genomics In Cancer Care Players Market Share
  • 3.2.2 Top 10 Genomics In Cancer Care Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Genomics In Cancer Care Revenue and Market Share by Regions
• 4.2 North America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 4.3 Europe Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 4.5 South America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

5 North America Genomics In Cancer Care Revenue by Countries

• 5.1 North America Genomics In Cancer Care Revenue by Countries (2015-2020)
• 5.2 USA Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 5.3 Canada Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

6 Europe Genomics In Cancer Care Revenue by Countries

• 6.1 Europe Genomics In Cancer Care Revenue by Countries (2015-2020)
• 6.2 Germany Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 6.3 UK Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 6.4 France Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 6.5 Russia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 6.6 Italy Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Genomics In Cancer Care Revenue by Countries

• 7.1 Asia-Pacific Genomics In Cancer Care Revenue by Countries (2015-2020)
• 7.2 China Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 7.3 Japan Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 7.4 Korea Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 7.5 India Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

8 South America Genomics In Cancer Care Revenue by Countries

• 8.1 South America Genomics In Cancer Care Revenue by Countries (2015-2020)
• 8.2 Brazil Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Genomics In Cancer Care by Countries

• 9.1 Middle East & Africa Genomics In Cancer Care Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 9.3 UAE Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Genomics In Cancer Care Revenue and Market Share by Type (2015-2020)
• 10.2 Global Genomics In Cancer Care Market Forecast by Type (2019-2024)
• 10.3 Instruments Revenue Growth Rate (2015-2025)
• 10.4 Consumables Revenue Growth Rate (2015-2025)
• 10.5 Services Revenue Growth Rate (2015-2025)

11 Global Genomics In Cancer Care Market Segment by Application

• 11.1 Global Genomics In Cancer Care Revenue Market Share by Application (2015-2020)
• 11.2 Genomics In Cancer Care Market Forecast by Application (2019-2024)
• 11.3 Diagnostics Revenue Growth (2015-2020)
• 11.4 Personalized Medicine Revenue Growth (2015-2020)
• 11.5 Drug Discovery Revenue Growth (2015-2020)
• 11.6 Development Revenue Growth (2015-2020)
• 11.7 Research Revenue Growth (2015-2020)

12 Global Genomics In Cancer Care Market Size Forecast (2021-2025)

• 12.1 Global Genomics In Cancer Care Market Size Forecast (2021-2025)
• 12.2 Global Genomics In Cancer Care Market Forecast by Regions (2021-2025)
• 12.3 North America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
• 12.4 Europe Genomics In Cancer Care Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Genomics In Cancer Care Revenue Market Forecast (2021-2025)
• 12.6 South America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Genomics In Cancer Care Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer